Assessing the effectiveness of tafamidis therapy in patients with transthyretin cardiac amyloidosis using ^99mtechnetium pyrophosphate cardiac imaging

J Nucl Cardiol. 2024 Nov 8:102075. doi: 10.1016/j.nuclcard.2024.102075. Online ahead of print.

Authors

Tatsuro Tasaka¹, Akiyoshi Ogimoto², Makoto Saito³, Shota Koike¹, Tamami Kono¹, Kiyotaka Ohshima¹, Mareomi Hamada¹

Affiliations

¹ Division of Cardiology, Uwajima City Hospital, Uwajima, Japan.
² Division of Cardiology, Uwajima City Hospital, Uwajima, Japan. Electronic address: [email protected].
³ Department of Cardiology, Kitaishikai Hospital, Ehime, Japan.

PMID: 39522711
DOI: 10.1016/j.nuclcard.2024.102075

No abstract available

Keywords: Clinical data; Myocardial accumulation; Tafamidis; Technetium pyrophosphate scintigraphy; Transthyretin cardiac amyloidosis.